Annual FASB Update and Review

Monday, Nov. 24
9:00am - 12:30pm

(Check-In 9:00am )

Add to Calendar

Online

4.00 Credits

Member Price $140.00

^{Price will increase by $20 after 11/17}

Non-Member Price $205.00

^{Price will increase by $20 after 11/17}

Overview

This course provides a detailed discussion on the key topics related to financial reporting, though in a summarized format. The course will focus on recent ASUs issued by the FASB with a concentration on issues of greatest significance to most accounting practitioners, including recently released ASUs. Specifically, the course will review recently issued FASB standards on leases and provide an update on ASC 842 and ASC 326 post-implementation items and other hot button accounting issues, such as what is on the FASB’s technical agenda. This course is the place to go for a succinct but thorough update on the big topics impacting financial accounting and reporting.

Objectives

Be aware of recent private company standard setting activities

Review the latest FASB Accounting Standards Updates (ASUs)

Understand the recently implemented lease accounting guidance found in Topic 842, Leases

Recall key provisions of recently issued FASB Updates

Understand the key provisions and updates to Topic 326, Current and Expected Credit Losses (CECL)

Highlights

Private company standard setting activities

Recent FASB Accounting Standards Updates (ASUs), including those addressing crypto assets (i.e., cryptocurrency)

Topic 842, Leases

ASC 326: CECL

Designed For

Practicing CPAs and their staffs, both in public accounting and business and industry, as well as controllers, accountants, and other financial accounting personnel involved in financial statement preparation and review

Prerequisites

Experience in financial accounting and reporting

Preparation

None

Notice

By registering for this program and, accordingly, receiving the eMaterials, you’re acknowledging that you understand both the copyright restrictions on your eMaterials and the CTCPA cancellation policy.